Regencell Bioscience (RGC) vs SNDL (SNDL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
SNDL (SNDL) has outperformed Regencell Bioscience (RGC) over the past year, losing 56.7% versus a loss of 60.1%. Over five years, RGC leads with a +1398.5% price change compared with -81.4% for SNDL. Regencell Bioscience is the larger company by market cap ($3.64 billion vs $300.3 million), about 12.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RGC | SNDL |
|---|---|---|
| Share price | $7.35 | $1.22 |
| Market cap | $3.64B | $300.27M |
| 1-day change | -3.67% | 0.00% |
| YTD return | -65.00% | -26.51% |
| 1-year return | -60.14% | -56.66% |
| 5-year return | +1398.47% | -81.40% |
| Forward P/E | — | 40.67 |
| EPS (TTM) | $-0.02 | $-0.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-11.70M | — |
| 52-week high | $69.00 | $2.60 |
| 52-week low | $4.51 | $1.17 |
| Distance from 52-week high | -89.35% | -53.04% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +184.43% |
| Average volume | 196.76K | 1.53M |
| Shares outstanding | 495.88M | 246.12M |
| Employees | 10 | 2,751 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Regencell Bioscience is about 12.1 times larger than SNDL by market value ($3.64B vs $300.27M).
About Regencell Bioscience
RGC stock →Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder.
Health Care · Medicinal Chemicals and Botanical Products · 10 employees
About SNDL
SNDL stock →SNDL Inc. engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada and internationally.
Health Care · Medicinal Chemicals and Botanical Products · 2,751 employees
RGC vs SNDL FAQ
Which is bigger, Regencell Bioscience or SNDL?
Regencell Bioscience (RGC) is larger, with a market capitalization of $3.64B compared with $300.27M for SNDL (SNDL).
Which stock has performed better over the past year, RGC or SNDL?
SNDL returned -56.66% over the past 12 months, compared with -60.14% for RGC (price return, excluding dividends). Past performance does not predict future results.
Are Regencell Bioscience and SNDL in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.